National Institute of Cancer Research
 
Skip to content
  • News
    • Press Conference
    • Symposium
    • Award
    • Career
  • About NICR
    • Introduction
    • Organization
    • History
    • Contact
  • Research
    • Objectives
    • Framework
  • Achievements
    • Publications
    • NHRI Communications
    • Experimental Therapeutics Study Program
    • Upper Aerodigestive Tract Cancer Study Program
    • Pancreatic Cancer Study Program
    • Glandular Malignancies Study Program
  • Investigators
  • TCOG
  • NHRI
  • en
    • tw
Home Archive by category "Press Conference"

Category: Press Conference

Sharing Taiwan Experience in Areca Nut and Betel Quid Control

NICR 2020-12-30 2020-12-30Press Conference

Oral cancer is a major public health problem in Taiwan. It is largely attributable to the widespread areca nut and betel quid chewing habit. Based on national health surveys, the betel quid chewing rates in Taiwan have declined since 2007.

Continue reading

A Novel Chemotherapy Regimen (SLOG) in Metastatic Pancreatic Cancer with Promising Efficacies

NICR 2020-12-02 2020-12-11Press Conference

NHRI has established a novel chemotherapy regimen, SLOG, with promising activity and safety profiles in the treatment of metastatic pancreatic cancer.
The result of TCOG T1211 SLOG study was published in European Journal of Cancer (https://www.ejcancer.com/article/S0959-8049(19)30795-6/fulltext).

Continue reading

The Influence of Alcohol on the Risk and Survival of Head and Neck Cancer

NICR 2019-12-06 2020-12-03Press Conference

The NICR published the research result of “The Influence of Alcohol on the Risk and Survival of Head and Neck Cancer
” (Sci Rep. 2017 Aug 29;7(1):9701). The article was reported in No. 819 of NHRI Communications (Chinese Version). 

Continue reading

NICR established the Cell-based Therapeutic Unit in collaboration with the National Cheng Kung University Hospital

NICR 2019-09-26 2020-12-03Press Conference

NICR established the Cell-based Therapeutic Unit in collaboration with the National Cheng Kung University Hospital on Sep. 26, 2019. The article was reported in No. 812 of NHRI Communications (Chinese Version). 

Continue reading

First cancer drug to begin its clinical development in Taiwan

NICR 2015-12-03 2020-05-22Press Conference

The NICR published the research result of “Nanoliposomal irinotecan with 5-fluorouracil and leucovorin in metastatic pancreatic cancer after prior gemcitabine-based therapy (NAPOLI-1): a global, randomized, open-label phase 3 trial. ” (Lancet 2016 Feb;387(10018):545-57). The article was reported in No. 631 of NHRI Communications (Chinese Version). 

Continue reading

  • News

    • News
    • Press Conference
    • Award
    • Symposium
    • Career
  • Press Conference

    • Sharing Taiwan Experience in Areca Nut and Betel Quid Control
    • The result of phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study
    • The Influence of Alcohol on the Risk and Survival of Head and Neck Cancer
    • NICR established the Cell-based Therapeutic Unit in collaboration with the National Cheng Kung University Hospital
    • First cancer drug to begin its clinical development in Taiwan
  • Award

    • The Research Team of Dr. Alan Yueh-Luen Lee Receives the 17th National Innovation Award
    • Prof. Li-Tzong Chen receives 6th National Industrial Innovation Award
    • Dr. Neng-Yao Shih, Dr. Li-Tzong Chen and Dr. Ko-Jiunn Liu receive 2018 Taipei Biotech Awards
    • Prof. Li-Tzong Chen receives 2017 MOST Outstanding Research Award
    • More Awards
  • Speech

    • 2020 Advanced Medical Device Training Course — On-line Video
    • 2020 Forum for Cancer Precision Medicine
    • 2019/10/18 Cancer Symposium
    • 3rd Asia-Pacific Cholangiocarcinoma Conference
  • Career

    • Seeking Postdoctoral Fellow for Lab of Dr. Ya-Wen Chen
    • Seeking Research Assistant for Lab of Dr. Yi-Hsin Yang
    • Seeking Assistant Investigator for Project of NICR
    • Seeking Research Assistant for Lab of Dr. Yi-Hsin Yang
    • More careers
Copyright National Institute of Cancer Research, National Health Research Institutes
35 Keyan Road, Zhunan, Miaoli County 35053, Taiwan (R.O.C.) ︱Tel: +886-37-206-166
35053苗栗縣竹南鎮科研路35號
No. 367, Sheng Li Road, Tainan 704, Taiwan (R.O.C.) ︱TEL: +886-6-700-0123
704台南市勝利路367號
Powered by Nirvana & WordPress.